The Seattle Times | March 23, 2022
Jesse Fann, MD, MPH, works with many immunocompromised patients who leave home only for doctor appointments or essentials like prescriptions and groceries. Such isolation can bring depression.
News & Stories
Psychedelics played role in Wallace Falls hiker’s death, police say
KING 5 | March 23, 2022
Mushrooms can make people hallucinate, act impulsively and not think of any potential consequences for their actions. “As psychedelics become culturally more normative, it's really important that people know they should do them in a controlled environment," says Nathan Sackett, MD, MS.
As he runs for Congress, Reagan Dunn recounts battle with alcoholism, and his recovery
The Seattle Times | March 20, 2022
Over the past few years, Reagan Dunn has spoken openly about his battles with alcohol and his recovery. “It is very common for people to have a drink again after being in some sort of period of sobriety,” says Mandy Owens, PhD.
Creating connections with the African American community to find the best ways to assess cognitive aging and mental health during a pandemic
ARDC News | March 17, 2022
Debby Tsuang, MD, MSc, and her team are researching the best remote health tools to assess mental health symptoms for African Americans and better include them in research. Written by Lori Mae Yvette Calibuso Acob, Brain Health Science Writing intern at the Garvey Institute for Brain Health Solutions.
WA state psychologists to train volunteers in Poland who in turn will support Ukrainian refugees
FOX 13 | March 4, 2022
A group of local psychologists, including Eric Bruns, PhD, are answering a request to travel to southeastern Poland to provide trauma-informed behavioral health training to hundreds of volunteers working with Ukrainian refugees.
New CDC guidelines on treating pain
KGMI Radio | March 3, 2022
Mark Sullivan, MD, PhD, says the CDC is trying to make the use of opioids for pain treatments easier and safer.
New Disruptive Behavior Intensive Outpatient Program at Seattle Children’s
Department news | February 28, 2022
A new Disruptive Behavior Intensive Outpatient Program (DB-IOP) based at Seattle Children’s will provide evidence-based treatment for parents and caregivers of children who struggle with unsafe behaviors including aggression and property destruction.
Behavioral Health Support Specialist (BHSS) Project
Department news | February 28, 2022
With generous support from Ballmer Group, we continue to build academic and structural support for a new role to help expand the behavioral health workforce in Washington.
Allana Hall receives Margaret H. O’Donnell Prize in Psychiatry
Department news | February 28, 2022
Congratulations to Allana Hall, a 4th year medical student, for receiving the Margaret H. O’Donnell Prize in Psychiatry.
Seattle’s psychedelic revolution has arrived
Seattle Met | February 22, 2022
Seattle became the largest U.S. city to decriminalize psychedelic drugs. To be clear, decriminalization isn’t legalization, and the gateway legislation doesn’t apply to LSD, MDMA or ketamine. But it may signal a more permissive psychedelic future. Nathan Sackett, MD, RS, RN, is quoted.
